An Innovative and Linguistically-Tailored Mobile Intervention to Improve Follow-Up for Abnormal Pap Test Results: CervixChat
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cervical Carcinoma
- Sponsor
- Thomas Jefferson University
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- Patient Consent Rate
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
This clinical trial evaluates the feasibility of a linguistically-tailored mobile intervention, called CervixChat in improving the follow-up of patients with abnormal Papanicolaou (pap) test results. A text messaging program, such as CervixChat may support patients who need a colposcopy.
Detailed Description
PRIMARY OBJECTIVE: I. To evaluate the feasibility of CervixChat intervention in a mix method design, through participants consent rate and the study completion rate. SECONDARY OBJECTIVE: I. To evaluate the acceptability of CervixChat intervention using a validated Likert-scale participant satisfaction questionnaire, as well as participant's interview data. EXPLORATORY OBJECTIVE: I. To evaluate the preliminary impact of CervixChat intervention, by comparing the colposcopy appointment adherence rate in the study cohort against a 1:1 matched control sample selected based on matching age, race and ethnicity, from participants at Jefferson Obstetrics and Gynecology (Ob-Gyn) department scheduled for a colposcopy in 2019. OUTLINE: Patients receive text messages for 1-2 months before scheduled appointment. Patients also complete a survey at baseline and after standard of care colposcopy and an interview after standard of care colposcopy. After completion of study, patients are followed up periodically.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Female, aged 21 to 65 years of age
- •Had received an abnormal Pap smear result
- •Scheduled colposcopy
- •Able to communicate with ease in English or Spanish
- •Have a cell phone with text (TXT) ability
- •Competent to give consent
Exclusion Criteria
- •Are pregnant at the time of recruitment
- •Display current evidence of positive invasive carcinoma of the cervix
Outcomes
Primary Outcomes
Patient Consent Rate
Time Frame: Up to 12 months
Study Completion Rate
Time Frame: Up to 12 months